• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用于皮肤给药的丁丙诺啡和布比卡因负载侵入体开发中影响变量的优化

Optimization of Influential Variables in the Development of Buprenorphine and Bupivacaine Loaded Invasome for Dermal Delivery.

作者信息

Babaie Soraya, Taghvimi Arezou, Charkhpour Mohammad, Zarebkohan Amir, Keyhanvar Peyman, Hamishehkar Hamed

机构信息

Pharmaceutical Analysis Research Center, Student Research Committee, and Faculty of Advanced Medical Science, Tabriz University of Medical Sciences, Tabriz, Iran.

Biotechnology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran.

出版信息

Adv Pharm Bull. 2021 May;11(3):522-529. doi: 10.34172/apb.2021.060. Epub 2020 Sep 19.

DOI:10.34172/apb.2021.060
PMID:34513627
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8421627/
Abstract

Hydrophilic drugs are extensively applied in clinical applications. Inadequate dermal penetration of these drugs is a great challenge. Incorporation of drugs into nano-carrier systems overcomes lower penetration drawbacks. Invasomes are novel nano-carrier systems which enhance transdermal penetration by using terpene and ethanol in their structures. buprenorphine and bupivacaine hydrochlorides are two potent analgesic drugs that are loaded simultaneously in the nano-invasome structure as opioid and non-opioid drugs. The full factorial experimental design was used for planning and estimating optimum formulations of invasome systems. Three influential factors like terpene type, terpene concentration and preparation method were comprehensively analyzed for achieving high encapsulation efficiency (EE) and optimum size. The mean sizes of designed invasomes were in the range of 0.39-5.86 µm and high values of EE and loading capacity (LC) were reported as 98.77 and 19.75 for buprenorphine-loaded invasome, respectively. Zeta potential measurements confirmed that the obtained high value of EE might be as a result of reversible ionic interactions between positively charged drugs and negatively charged phospholipidic part of invasome structure. Another characterization of the prepared formulations was carried out by Fourier transform infrared (FTIR), X-ray diffraction (XRD) and dynamic light scattering (DLS) technique. The satisfactory obtained results of formulations encourage researchers to get optimum topical analgesic formulations with potent and rapid onset time properties required in invasive cutaneous procedures.

摘要

亲水性药物在临床应用中被广泛使用。这些药物的皮肤渗透不足是一个巨大的挑战。将药物纳入纳米载体系统可克服渗透较低的缺点。侵入体是新型纳米载体系统,其通过在结构中使用萜烯和乙醇来增强透皮渗透。丁丙诺啡和盐酸布比卡因是两种强效镇痛药,作为阿片类和非阿片类药物同时负载在纳米侵入体结构中。全因子实验设计用于规划和评估侵入体系统的最佳配方。为了实现高包封率(EE)和最佳尺寸,对萜烯类型、萜烯浓度和制备方法这三个影响因素进行了综合分析。设计的侵入体的平均尺寸在0.39 - 5.86 µm范围内,载有丁丙诺啡的侵入体的EE和载药量(LC)的高值分别报告为98.77和19.75。zeta电位测量证实,获得的高EE值可能是由于带正电的药物与侵入体结构中带负电的磷脂部分之间的可逆离子相互作用。通过傅里叶变换红外(FTIR)、X射线衍射(XRD)和动态光散射(DLS)技术对制备的制剂进行了另一项表征。制剂获得的令人满意的结果鼓励研究人员获得具有侵入性皮肤手术所需的强效和快速起效特性的最佳局部镇痛制剂。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e4/8421627/e0b61de9c0b0/apb-11-522-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e4/8421627/789824794173/apb-11-522-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e4/8421627/ea18683515c8/apb-11-522-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e4/8421627/2f982558ef8a/apb-11-522-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e4/8421627/9e3c6538e00d/apb-11-522-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e4/8421627/3629dac2ed97/apb-11-522-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e4/8421627/4a2bd55e5721/apb-11-522-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e4/8421627/e0b61de9c0b0/apb-11-522-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e4/8421627/789824794173/apb-11-522-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e4/8421627/ea18683515c8/apb-11-522-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e4/8421627/2f982558ef8a/apb-11-522-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e4/8421627/9e3c6538e00d/apb-11-522-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e4/8421627/3629dac2ed97/apb-11-522-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e4/8421627/4a2bd55e5721/apb-11-522-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/07e4/8421627/e0b61de9c0b0/apb-11-522-g007.jpg

相似文献

1
Optimization of Influential Variables in the Development of Buprenorphine and Bupivacaine Loaded Invasome for Dermal Delivery.用于皮肤给药的丁丙诺啡和布比卡因负载侵入体开发中影响变量的优化
Adv Pharm Bull. 2021 May;11(3):522-529. doi: 10.34172/apb.2021.060. Epub 2020 Sep 19.
2
Nano-invasomes for simultaneous topical delivery of buprenorphine and bupivacaine for dermal analgesia.用于同时递送达泊啡酮和布比卡因的经皮镇痛的纳米侵袭体。
Exp Dermatol. 2023 Sep;32(9):1459-1467. doi: 10.1111/exd.14850. Epub 2023 Jun 7.
3
Invasome: A Novel Nanocarrier for Transdermal Drug Delivery.侵入体:一种用于透皮给药的新型纳米载体。
Nanomaterials (Basel). 2020 Feb 17;10(2):341. doi: 10.3390/nano10020341.
4
Development of different temoporfin-loaded invasomes-novel nanocarriers of temoporfin: characterization, stability and in vitro skin penetration studies.不同载有替莫泊芬的侵入体(替莫泊芬新型纳米载体)的研发:表征、稳定性及体外皮肤渗透研究
Colloids Surf B Biointerfaces. 2009 May 1;70(2):198-206. doi: 10.1016/j.colsurfb.2008.12.030. Epub 2008 Dec 27.
5
Nanoethosomes for Dermal Delivery of Lidocaine.用于利多卡因经皮给药的纳米脂质体
Adv Pharm Bull. 2015 Nov;5(4):549-56. doi: 10.15171/apb.2015.074. Epub 2015 Nov 30.
6
Transdermal application of diacerin loaded-terpene enriched invasomes: an approach to augment anti-edema and nociception inhibition activity.富含萜烯的载双醋瑞因侵入体的透皮给药:增强抗水肿和抑制伤害感受活性的一种方法。
J Liposome Res. 2025 Mar;35(1):1-14. doi: 10.1080/08982104.2024.2382974. Epub 2024 Jul 29.
7
Invasomes for Enhanced Delivery through the Skin: Evaluation of Systems to Meet with Clinical Challenges.经皮递药增强用入侵体:满足临床挑战的系统评估。
Pharm Nanotechnol. 2021;9(5):317-325. doi: 10.2174/2211738510666211220142126.
8
Design, formulation and optimization of novel soft nano-carriers for transdermal olmesartan medoxomil delivery: In vitro characterization and in vivo pharmacokinetic assessment.用于透皮递送奥美沙坦酯的新型软纳米载体的设计、配方及优化:体外表征与体内药代动力学评估
Int J Pharm. 2016 May 30;505(1-2):147-58. doi: 10.1016/j.ijpharm.2016.03.030. Epub 2016 Mar 19.
9
Temoporfin-loaded invasomes: development, characterization and in vitro skin penetration studies.载有替莫泊芬的侵入体:研发、表征及体外皮肤渗透研究
J Control Release. 2008 Apr 7;127(1):59-69. doi: 10.1016/j.jconrel.2007.12.013. Epub 2007 Dec 26.
10
Tailoring novel soft nano-vesicles 'Flexosomes' for enhanced transdermal drug delivery: Optimization, characterization and comprehensive ex vivo - in vivo evaluation.定制新型软纳泡 'Flexosomes' 以增强经皮药物传递:优化、表征和全面的离体 - 体内评估。
Int J Pharm. 2019 Apr 5;560:101-115. doi: 10.1016/j.ijpharm.2019.01.072. Epub 2019 Feb 10.

引用本文的文献

1
Assessment of the Anti-Inflammatory Effectiveness of Diclofenac Encapsulated in Chitosan-Coated Lipid Microvesicles in Rats.壳聚糖包被脂质微泡包裹双氯芬酸对大鼠抗炎效果的评估
Pharmaceutics. 2025 May 3;17(5):607. doi: 10.3390/pharmaceutics17050607.
2
Influence of the Acceptor Fluid on the Bupivacaine Release from the Prospective Intra-Articular Methylcellulose Hydrogel.受体液对布比卡因从预期的关节内甲基纤维素水凝胶中释放的影响。
Pharmaceutics. 2024 Jun 27;16(7):867. doi: 10.3390/pharmaceutics16070867.
3
Pain management in pediatric age. An update.

本文引用的文献

1
Vesicular carriers containing phenylethyl resorcinol for topical delivery system; liposomes, transfersomes and invasomes.用于局部给药系统的含有苯乙基间苯二酚的囊泡载体;脂质体、传递体和侵入体。
Asian J Pharm Sci. 2018 Sep;13(5):472-484. doi: 10.1016/j.ajps.2018.02.004. Epub 2018 Mar 17.
2
Dapsone-Loaded Invasomes as a Potential Treatment of Acne: Preparation, Characterization, and In Vivo Skin Deposition Assay.载双氯苯双胍己烷侵入体治疗痤疮的潜力:制备、表征和体内皮肤沉积试验。
AAPS PharmSciTech. 2018 Jul;19(5):2174-2184. doi: 10.1208/s12249-018-1025-0. Epub 2018 May 3.
3
The role of surfactants in the formulation of elastic liposomal gels containing a synthetic opioid analgesic.
儿科疼痛管理。最新进展。
Acta Biomed. 2023 Aug 3;94(4):e2023174. doi: 10.23750/abm.v94i4.14289.
4
Recent advances in pain management based on nanoparticle technologies.基于纳米颗粒技术的疼痛管理新进展。
J Nanobiotechnology. 2022 Jun 18;20(1):290. doi: 10.1186/s12951-022-01473-y.
表面活性剂在含有合成阿片类镇痛药的弹性脂质体凝胶制剂中的作用。
Int J Nanomedicine. 2016 Apr 8;11:1475-82. doi: 10.2147/IJN.S100253. eCollection 2016.
4
Invasomes of isradipine for enhanced transdermal delivery against hypertension: formulation, characterization, and in vivo pharmacodynamic study.异搏定包封体用于增强高血压经皮递送的研究:制剂、表征和体内药效学研究。
Artif Cells Nanomed Biotechnol. 2017 Feb;45(1):139-145. doi: 10.3109/21691401.2016.1138486. Epub 2016 Feb 1.
5
Topical local anesthesia: focus on lidocaine-tetracaine combination.局部麻醉:聚焦于利多卡因-丁卡因合剂
Local Reg Anesth. 2015 Nov 27;8:95-100. doi: 10.2147/LRA.S41836. eCollection 2015.
6
Effect of borneol on the transdermal permeation of drugs with differing lipophilicity and molecular organization of stratum corneum lipids.冰片对不同亲脂性药物经皮渗透及角质层脂质分子结构的影响
Drug Dev Ind Pharm. 2016;42(7):1086-93. doi: 10.3109/03639045.2015.1107095. Epub 2015 Dec 4.
7
Actions of bupivacaine, a widely used local anesthetic, on NMDA receptor responses.广泛使用的局部麻醉药布比卡因对NMDA受体反应的作用。
J Neurosci. 2015 Jan 14;35(2):831-42. doi: 10.1523/JNEUROSCI.3578-14.2015.
8
Liposomes as carriers of hydrophilic small molecule drugs: strategies to enhance encapsulation and delivery.脂质体作为亲水性小分子药物的载体:增强包封和递送的策略。
Colloids Surf B Biointerfaces. 2014 Nov 1;123:345-63. doi: 10.1016/j.colsurfb.2014.09.029. Epub 2014 Sep 22.
9
The δ-opioid receptor affects epidermal homeostasis via ERK-dependent inhibition of transcription factor POU2F3.δ-阿片受体通过 ERK 依赖性抑制转录因子 POU2F3 影响表皮稳态。
J Invest Dermatol. 2015 Feb;135(2):471-480. doi: 10.1038/jid.2014.370. Epub 2014 Sep 1.
10
Epidermal adrenergic signaling contributes to inflammation and pain sensitization in a rat model of complex regional pain syndrome.表皮肾上腺素能信号在复杂性区域疼痛综合征大鼠模型中的炎症和痛觉过敏中起作用。
Pain. 2013 Aug;154(8):1224-36. doi: 10.1016/j.pain.2013.03.033. Epub 2013 Apr 12.